Autor segons l'article: Plans-Galván O; Daniel X; Rosich S; Blázquez-Alcaide V; Gil-Castillejos D; Bodí M
Departament: Medicina i Cirurgia
Autor/s de la URV: Bodi Saera, Maria Amparo
Paraules clau: Epilepsy super-refractory status epilepticus status epilepticus sedation isoflurane epileptic seizures
Resum: Super-refractory status epilepticus (SRSE) is a neurological condition with an important morbidity and mortality rate, for which few therapeutic options are available. Inhalation sedation with isoflurane is currently a compassionate-use treatment in Spanish intensive care units. Little has been written about its usefulness in the treatment of refractory and super-refractory status epilepticus, but it appears to be a useful and safe therapeutic alternative for this condition.This article reviews three cases of SRSE treated with isoflurane. The capacity of isoflurane to control seizures was assessed by electroencephalographic monitoring. Other variables assessed were time to seizure control, survival, functional outcome and occurrence of complications secondary to isoflurane. In the three cases reviewed, isoflurane proved to be effective for seizure control in patients affected by SRSE. Seizure control was accomplished quickly and the minimum dose required to obtain a burst-suppression pattern was titrated easily and rapidly. Despite controlling epilepsy, high mortality was observed (66.66%). This is explained by both the mortality of SRSE and the underlying pathologies of the patients who died. The use of isoflurane did not give rise to any complications.With the results obtained, it is feasible to think that the use of isoflurane is not related to lesions in the central nervous system reported in other articles, and this treatment can be considered effective and safe for the control of SRSE.
Àrees temàtiques: Saúde coletiva Psicología Neurology (clinical) Medicine (miscellaneous) Medicine (all) Medicina iii Medicina ii Medicina i Interdisciplinar General medicine Farmacia Engenharias iv Engenharias iii Educação física Clinical neurology Ciências biológicas ii Ciências biológicas i
Accès a la llicència d'ús: https://creativecommons.org/licenses/by/3.0/es/
Adreça de correu electrònic de l'autor: mariaamparo.bodi@urv.cat mariaamparo.bodi@urv.cat
Identificador de l'autor: 0000-0001-7652-8379 0000-0001-7652-8379
Data d'alta del registre: 2024-08-03
Versió de l'article dipositat: info:eu-repo/semantics/publishedVersion
Enllaç font original: https://neurologia.com/articulo/2022191
URL Document de llicència: https://repositori.urv.cat/ca/proteccio-de-dades/
Referència a l'article segons font original: Revista De Neurologia. 76 (9): 309-312
Referència de l'ítem segons les normes APA: Plans-Galván O; Daniel X; Rosich S; Blázquez-Alcaide V; Gil-Castillejos D; Bodí M (2023). [Use of isoflurane as treatment for super-refractory status epilepticus]. Revista De Neurologia, 76(9), 309-312. DOI: 10.33588/rn.7609.2022191
DOI de l'article: 10.33588/rn.7609.2022191
Entitat: Universitat Rovira i Virgili
Any de publicació de la revista: 2023
Tipus de publicació: Journal Publications